- Home
- Supplements
- Saffron
- Seasonal Mood Support
Saffron for Seasonal Mood Support
Saffron has surprisingly consistent antidepressant trial data for a spice.
Overview
Verdict
Meta-analysed randomised trials show saffron beating placebo and matching standard antidepressants on depression severity and anhedonia. Evidence is from major depression, not seasonal presentations specifically.
How It Works
Pathways involved
Dosing & Protocol
| Context | Dose | Form | Timing |
|---|---|---|---|
| Standard trial dose | 30 mg daily | Standardised saffron extract | Split 15 mg twice daily with food |
| Alternative regimen | 28-30 mg daily | Affron or similar standardised extract | Single morning dose |
| Standardisation to look for | 2% safranal or 3% crocin | Standardised extract | Stated on the label |
- 1
Verify standardisation before buying· Before starting
Saffron is one of the most adulterated ingredients in the supplement market. Only standardised extracts with a stated crocin or safranal content match the trials.
- 2
Take 30 mg daily, split or morning· Daily
Trials used 15 mg twice daily; single-dose regimens at 28-30 mg have also shown effects.
- 3
Pair with morning light· Every morning
Ten to thirty minutes of bright light within an hour of waking addresses the circadian component saffron does not touch.
- 4
Review at six to eight weeks· Week 6-8
Trial durations were typically six to eight weeks. Use a repeatable mood scale rather than recall.
Culinary saffron is not the dose
The threads in your kitchen are not standardised and the quantities used in cooking are far below 30 mg of extract. This effect requires a standardised supplement.
Evidence
Studies linked to this pairing.
Saffron for major depressive disorder and anhedonia: a systematic review and meta-analysis
Hausenblas HA, Saha D, Dubyak PJ +1 more
Saffron significantly outperformed placebo and matched standard antidepressants on depression severity
- Best available evidence
- Systematic review and meta-analysis in major depressive disorder and anhedonia
- Typical effect
- Superior to placebo; comparable to standard antidepressants
- Studied dose
- 30 mg daily of standardised extract
- Time to effect
- 6-8 weeks
- Main limitation
- Small trials from few research groups; no seasonal-specific randomisation
Safety
Do not self-treat significant depression
If low mood is persistent, disabling, or accompanied by thoughts of self-harm, that needs clinical care. Saffron is not a substitute for assessment or prescribed treatment.
Common effects
Interactions & Conflicts
| Interacts with | Severity | Mechanism | Action |
|---|---|---|---|
| SSRIs and SNRIs | moderate | Shared serotonergic activity; theoretical additive risk | Only combine with prescriber knowledge |
| MAOIs | high | Serotonergic additive risk | Avoid |
| Anticoagulants | moderate | Antiplatelet activity reported at higher doses | Discuss with a prescriber before use |
| Antihypertensives | low | Mild blood pressure lowering reported | Monitor if already well controlled |
References
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.